Real-World Efficacy and Safety of Tafluprost in Primary Open-Angle Glaucoma Patients with Corneal Disorders: A Taiwan Experience

Table 2

Results of fluorescein staining scores (NEI scale) at each visit.

Location	Visit 0	Visit 1	Visit 2
Central	1.2 ± 0.6	1.1 ± 0.5	1.1 ± 0.4
Change from V0	N/A	−0.1 ± 0.2	−0.1 ± 0.3
-value		0.332	0.164
Superior	1.3 ± 0.8	1.1 ± 0.2	1.0 ± 0.4
Change from V0	N/A	−0.2 ± 0.7	−0.3 ± 0.6
-value		0.164	0.056
Inferior	1.5 ± 0.7	1.1 ± 0.2	1.1 ± 0.2
Change from V0	N/A	−0.4 ± 0.6	−0.4 ± 0.6
-value		<0.05	<0.05
Temporal	1.5 ± 0.7	1.1 ± 0.3	1.1 ± 0.4
Change from V0	N/A	−0.4 ± 0.6	−0.5 ± 0.6
-value		<0.05	<0.01
Nasal	1.6 ± 0.8	1.2 ± 0.4	1.1 ± 0.5
Change from V0	N/A	−0.4 ± 0.6	−0.5 ± 0.6
-value		<0.05	<0.01
Overall	7.1 ± 3.2	5.5 ± 1.4	5.3 ± 1.8
Change from V0	N/A	−1.5 ± 2.3	−1.8 ± 2.2
-value		<0.05	<0.01

NEI, National Eye Institute.